+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Contract Manufacturing Market Research Report by Service, End-user, Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968717
  • Report
  • April 2022
  • Region: Global
  • 219 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AbbVie, Inc.
  • Amgen Inc.
  • Biozoc Inc.
  • Danaher Corporation
  • Lonza Group
  • Recipharm AB
The Global Pharmaceutical Contract Manufacturing Market size was estimated at USD 89,910.33 million in 2020, USD 97,178.18 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.33% to reach USD 145,359.22 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Service, the market was studied across Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services, and Secondary Packaging Services. The Biologics Manufacturing Services is further studied across Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. The Pharmaceutical Manufacturing Services is further studied across Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. The Pharmaceutical API Manufacturing is further studied across Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Parenteral/Injectable Manufacturing Services, and Tablet Manufacturing Services.
  • Based on End-user, the market was studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing Market, including AbbVie, Inc., Aenova Group GmbH, Almac Group, Amgen Inc., AMRI Global, Baxter International Inc., Biozoc Inc., C. H. Boehringer Sohn AG & Co. KG, Cambrex Corporation, Catalent, Inc., Danaher Corporation, Dr. Reddy’s Laboratories Ltd., Evonik Industries AG, Famar Health Care Services, Fareva, Jubilant Life Sciences Limited, Kryptochem Medicament Pvt. Ltd., Lonza Group, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare, Recipharm AB, Serum Institute of India Ltd., Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma International GMBH.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Contract Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?
Frequently Asked Questions about the Global Pharmaceutical Contract Manufacturing Market

What is the estimated value of the Global Pharmaceutical Contract Manufacturing Market?

The Global Pharmaceutical Contract Manufacturing Market was estimated to be valued at $89910.3 Million in 2020.

What is the growth rate of the Global Pharmaceutical Contract Manufacturing Market?

The growth rate of the Global Pharmaceutical Contract Manufacturing Market is 8.3%, with an estimated value of $145359.2 Million by 2026.

What is the forecasted size of the Global Pharmaceutical Contract Manufacturing Market?

The Global Pharmaceutical Contract Manufacturing Market is estimated to be worth $145359.2 Million by 2026.

Who are the key companies in the Global Pharmaceutical Contract Manufacturing Market?

Key companies in the Global Pharmaceutical Contract Manufacturing Market include AbbVie, Inc., Aenova Group GmbH, Almac Group, Amgen Inc., AMRI Global, Baxter International Inc., Biozoc Inc., C. H. Boehringer Sohn AG & Co. KG and Catalent, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie, Inc.
  • Amgen Inc.
  • Biozoc Inc.
  • Danaher Corporation
  • Lonza Group
  • Recipharm AB

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Demand for Generics and Biological Therapies
5.1.1.2. Increasing Investments in Pharmaceutical R&D and Manufacturing
5.1.1.3. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
5.1.2. Restraints
5.1.2.1. Introduction of Serialization Standards
5.1.3. Opportunities
5.1.3.1. Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
5.1.3.2. Growing Demand for Cell and Gene Therapies for Targeted Treatment
5.1.4. Challenges
5.1.4.1. Changing Trade Policies Between Countries
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Contract Manufacturing Market, by Service
6.1. Introduction
6.2. Biologics Manufacturing Services
6.2.1. Biologics API Manufacturing Services
6.2.2. Biologics FDF Manufacturing Services
6.3. Drug Development Services
6.4. Pharmaceutical Manufacturing Services
6.4.1. Pharmaceutical API Manufacturing
6.4.1.1. Capsule Manufacturing Services
6.4.1.2. Oral Liquid Manufacturing Services
6.4.1.3. Parenteral/Injectable Manufacturing Services
6.4.1.4. Tablet Manufacturing Services
6.4.2. Pharmaceutical FDF Manufacturing
6.5. Secondary Packaging Services
7. Pharmaceutical Contract Manufacturing Market, by End-user
7.1. Introduction
7.2. Big Pharma
7.3. Generic Pharmaceutical Companies
7.4. Small & Mid-Size Pharma
8. Americas Pharmaceutical Contract Manufacturing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pharmaceutical Contract Manufacturing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie, Inc.
12.2. Aenova Group GmbH
12.3. Almac Group
12.4. Amgen Inc.
12.5. AMRI Global
12.6. Baxter International Inc.
12.7. Biozoc Inc.
12.8. C. H. Boehringer Sohn AG & Co. KG
12.9. Cambrex Corporation
12.10. Catalent, Inc.
12.11. Danaher Corporation
12.12. Dr. Reddy’s Laboratories Ltd.
12.13. Evonik Industries AG
12.14. Famar Health Care Services
12.15. Fareva
12.16. Jubilant Life Sciences Limited
12.17. Kryptochem Medicament Pvt. Ltd.
12.18. Lonza Group
12.19. Mitsubishi Tanabe Pharma Corporation
12.20. Pfizer Inc.
12.21. Pidolma Healthcare
12.22. Recipharm AB
12.23. Serum Institute of India Ltd.
12.24. Siegfried Holding AG
12.25. Sycon Healthcare
12.26. Thermo Fisher Scientific Inc.
12.27. Vetter Pharma International GMBH
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: DYNAMICS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 VS 2026 (%)
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2026
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2026
FIGURE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 35. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 37. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 40. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 41. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 42. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 45. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 46. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 47. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 50. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 51. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 52. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY REGION, 2018-2026 (USD MILLION)
TABLE 55. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 56. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY STATE, 2018-2026 (USD MILLION)
TABLE 57. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 60. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 61. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 62. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 66. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 67. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY STATE, 2018-2026 (USD MILLION)
TABLE 68. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 71. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 72. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 73. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 76. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 77. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY STATE, 2018-2026 (USD MILLION)
TABLE 78. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 80. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 81. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 82. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 83. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 84. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 85. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 86. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 87. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 88. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 89. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 90. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 91. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 92. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 93. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 94. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 95. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 96. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 97. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 99. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 100. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 101. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 102. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 103. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 104. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 105. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 106. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 107. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 109. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SCORES
TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RANKING
TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AbbVie, Inc.
  • Aenova Group GmbH
  • Almac Group
  • Amgen Inc.
  • AMRI Global
  • Baxter International Inc.
  • Biozoc Inc.
  • C. H. Boehringer Sohn AG & Co. KG
  • Cambrex Corporation
  • Catalent, Inc.
  • Danaher Corporation
  • Dr. Reddy’s Laboratories Ltd.
  • Evonik Industries AG
  • Famar Health Care Services
  • Fareva
  • Jubilant Life Sciences Limited
  • Kryptochem Medicament Pvt. Ltd.
  • Lonza Group
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Pidolma Healthcare
  • Recipharm AB
  • Serum Institute of India Ltd.
  • Siegfried Holding AG
  • Sycon Healthcare
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma International GMBH
Note: Product cover images may vary from those shown

Loading
LOADING...